{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:47:21Z","timestamp":1772754441489,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.autrev.2008.07.009","type":"journal-article","created":{"date-parts":[[2008,8,10]],"date-time":"2008-08-10T08:22:49Z","timestamp":1218356569000},"page":"100-103","source":"Crossref","is-referenced-by-count":24,"title":["Treatment of rheumatic diseases in patients with HCV and HIV infection"],"prefix":"10.1016","volume":"8","author":[{"given":"Mauro","family":"Galeazzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Giannitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Manganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Benucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Scarpato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Bazzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Domenico","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.autrev.2008.07.009_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11926-003-0067-8","article-title":"Rheumatic manifestations of hepatitis C infection","volume":"5","author":"Vassilopoulos","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2008.07.009_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2005.06.031","article-title":"Watanabe M. Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins","volume":"129","author":"Nakagawa","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2008.07.009_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-4362.1999.00690.x","article-title":"Administration of cyclosporin A to HCV-antibody-positive patients with dermatologic diseases","volume":"38","author":"Long-term Miura","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2008.07.009_bib4","series-title":"Chronic HCV hepatitis treatment in patients with autoimmune manifestations with pegylated interferon, ribavirin and CsA. Presented at the SIMIT Congress. Fiuggi","author":"Rendina","year":"2005"},{"key":"10.1016\/j.autrev.2008.07.009_bib5","series-title":"Patients with lichen planus and HCV infection treated with CsA","first-page":"593","volume":"vol. 11","author":"Francavilla","year":"2005"},{"key":"10.1016\/j.autrev.2008.07.009_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2006.01.002","article-title":"Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients","volume":"5","author":"Galeazzi","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2008.07.009_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1196\/annals.1423.058","article-title":"Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection","volume":"1110","author":"Galeazzi","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2008.07.009_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4615-1995-9_18","article-title":"Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection","volume":"374","author":"Thomson","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2008.07.009_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2007.03.023","article-title":"Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity","volume":"565","author":"Chen","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.autrev.2008.07.009_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1099\/0022-1317-78-4-825","article-title":"The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells","volume":"78","author":"Mlynar","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.autrev.2008.07.009_bib11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1128\/AAC.01324-07","article-title":"Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent","volume":"52","author":"Ptak","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.autrev.2008.07.009_bib12","first-page":"79","article-title":"Cyclosporin A in combination with HAART in primary HIV-1 infection","volume":"14","author":"Rizzardi","year":"2000","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.autrev.2008.07.009_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4615-1995-9_20","article-title":"Long-term follow-up of HIV positive asymptomatic patients having received cyclosporin A","volume":"374","author":"Levy","year":"1995","journal-title":"Adv Exp Med Biol."},{"key":"10.1016\/j.autrev.2008.07.009_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00126334-200204010-00005","article-title":"AIDS Clinical Trials Group 334 Investigators. Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation","volume":"29","author":"Calabrese","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.autrev.2008.07.009_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0190-9622(97)70160-9","article-title":"Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine","volume":"37","author":"Tourne","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.autrev.2008.07.009_bib16","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.028209","article-title":"Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection","volume":"63","author":"Calabrese","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2008.07.009_bib17","first-page":"210","article-title":"Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C","volume":"23","author":"Larrea","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2008.07.009_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/kel191","article-title":"Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus","volume":"46","author":"Marotte","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2008.07.009_bib19","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/rheumatology\/kel123","article-title":"Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis","volume":"45","author":"Roux","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2008.07.009_bib20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.20702","article-title":"Reveille JD. Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection","volume":"51","author":"Parke","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2008.07.009_bib21","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/ard.62.11.1078","article-title":"Effect of tumor necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection","volume":"62","author":"Peterson","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2008.07.009_bib22","first-page":"107","article-title":"Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C","volume":"31","author":"Oniankitan","year":"2004","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2008.07.009_bib23","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10067-006-0412-1","article-title":"Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection","volume":"26","author":"Bellisai","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2008.07.009_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/ajrccm.151.1.7812542","article-title":"Accelerated course of human immunodeficiency virus infection after tuberculosis","volume":"151","author":"Whalen","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.autrev.2008.07.009_bib25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4065\/75.10.1093","article-title":"Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis","volume":"75","author":"Aboulafia","year":"2000","journal-title":"Mayo Clin Proc."},{"issue":"6","key":"10.1016\/j.autrev.2008.07.009_bib26","first-page":"1353","article-title":"Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection","volume":"34","author":"Linardaki","year":"2007","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2008.07.009_bib27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.0007-0963.2004.05885.x","article-title":"Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab","volume":"150","author":"Bartke","year":"2004","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2008.07.009_bib28","first-page":"407","article-title":"Infliximab in the treatment of an HIV positive patient with Reiter's syndrome","volume":"30","author":"Gaylis","year":"2003","journal-title":"J Rheumatol."},{"issue":"1","key":"10.1016\/j.autrev.2008.07.009_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10067-007-0692-0","article-title":"Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion","volume":"27","author":"Gill","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2008.07.009_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jbspin.2006.05.012","article-title":"Use of infliximab to treat psoriatic arthritis in HIV-positive patients","volume":"74","author":"Sellam","year":"2007","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.autrev.2008.07.009_bib31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2007.081513","article-title":"The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease","volume":"67","author":"Cepeda","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2008.07.009_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.rhu.0000260411.75599.39","article-title":"Successful etanercept use in an HIV-positive patient with rheumatoid arthritis","volume":"13","author":"Kaur","year":"2007","journal-title":"J Clin Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T11:24:58Z","timestamp":1738322698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997208001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1568997208001213"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2008.07.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}